The startup develops a bioprocess monitoring technology that utilizes chemometric methods for real-time analysis of key metrics such as glucose, lactate, and cell densities. This technology enables pharmaceutical companies to enhance process control and accelerate drug development while reducing costs.
Funding
$21.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Biopharmaceutical manufacturing processes require precise monitoring of critical parameters such as excipient and product concentrations to ensure product quality and consistency. Traditional analytical methods like HPLC are time-consuming, require specialized expertise, and often involve extensive sample preparation, leading to delays in process development and manufacturing.
Solution
Nirrin Technologies provides the Atlas system, a process analytical technology that enables real-time monitoring of key parameters in biomanufacturing. The Atlas system utilizes high-precision tunable laser spectroscopy (HPTLS) to provide rapid, quantitative analysis of complex bioprocess samples at-line, in-line, or in-situ. This allows for faster process development, improved process control, and advanced manufacturing capabilities. The Atlas system requires minimal sample preparation and can be operated by any user, delivering results in under one minute with only 15 microliters of sample.
Target Audience
The primary customers are biopharmaceutical companies involved in the development and manufacturing of biologics and advanced therapies.
Features
- High-precision tunable laser spectroscopy (HPTLS) for accurate and repeatable measurements
- Real-time analysis of excipients, proteins, and surfactants
- At-line, in-line, and in-situ monitoring capabilities
- Minimal sample preparation required
- Results in under one minute
- Small sample volume (15 microliters)
- Process-compatible form factors, including autoclavable in-situ probes and sterilizable flow cells